Literature DB >> 1623926

The murine IgG1/IgE class switch program.

G Siebenkotten1, C Esser, M Wabl, A Radbruch.   

Abstract

Immunoglobulin class switching is controlled by cytokines. Thus, interleukin-4 (IL-4) directs class switching to both IgG1 and IgE. Consistent with this are the results reported here on restriction endonuclease analysis of active and inactive alleles of the IgH locus in IgE-producing cells. In cells that were stimulated in vitro by lipopolysaccharide and IL-4 the silent alleles preferentially switched to gamma 1, whereas in cells that were stimulated by antigen in vivo both active and inactive alleles switched to epsilon. Thirty percent of the recombined switch regions (S mu/S epsilon) contain S gamma 1 sequences, which we interpret as footprints of a previous switch to gamma 1. Since this percentage is a minimum estimate, between 30% and 100% of switching to epsilon must occur sequentially via gamma 1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623926     DOI: 10.1002/eji.1830220723

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

1.  Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice.

Authors:  Hans D Brightbill; Surinder Jeet; Zhonghua Lin; Donghong Yan; Meijuan Zhou; Martha Tan; Allen Nguyen; Sherry Yeh; Donnie Delarosa; Steven R Leong; Terence Wong; Yvonne Chen; Mark Ultsch; Elizabeth Luis; Sree Ranjani Ramani; Janet Jackman; Lino Gonzalez; Mark S Dennis; Anan Chuntharapai; Laura DeForge; Y Gloria Meng; Min Xu; Charles Eigenbrot; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Lawren C Wu
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Antigen dose-dependent predominance of either direct or sequential switch in IgE antibody responses.

Authors:  S Sudowe; A Rademaekers; E Kölsch
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

Review 3.  Regulatory constraints in the generation and differentiation of IgE-expressing B cells.

Authors:  Zhiyong Yang; Marcus J Robinson; Christopher D C Allen
Journal:  Curr Opin Immunol       Date:  2014-03-12       Impact factor: 7.486

4.  Switch recombination in normal IgA1+ B lymphocytes.

Authors:  J Irsch; S Irlenbusch; J Radl; P D Burrows; M D Cooper; A H Radbruch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  Suppression of IgE B cells and IgE binding to Fc(epsilon)RI by gene therapy with single-chain anti-IgE.

Authors:  Takayuki Ota; Miyo Aoki-Ota; Bao Hoa Duong; David Nemazee
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

6.  Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells.

Authors:  J R Müller; M Potter; S Janz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

Review 7.  Limited humoral immunoglobulin E memory influences serum immunoglobulin E levels in blood.

Authors:  G Achatz-Straussberger; N Zaborsky; S Königsberger; S Feichtner; S Lenz; D Peckl-Schmid; M Lamers; G Achatz
Journal:  Clin Exp Allergy       Date:  2009-05-20       Impact factor: 5.018

8.  Maintenance of anti-Sm/RNP autoantibody production by plasma cells residing in ectopic lymphoid tissue and bone marrow memory B cells.

Authors:  Jason S Weinstein; Matthew J Delano; Yuan Xu; Kindra M Kelly-Scumpia; Dina C Nacionales; Yi Li; Pui Y Lee; Philip O Scumpia; Lijun Yang; Eric Sobel; Lyle L Moldawer; Westley H Reeves
Journal:  J Immunol       Date:  2013-03-18       Impact factor: 5.422

9.  Reprogramming IgH isotype-switched B cells to functional-grade induced pluripotent stem cells.

Authors:  Duane R Wesemann; Andrew J Portuguese; Jennifer M Magee; Michael P Gallagher; Xiaolong Zhou; Rohit A Panchakshari; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

Review 10.  Regulation of IgE by T follicular helper cells.

Authors:  Uthaman Gowthaman; Jennifer S Chen; Stephanie C Eisenbarth
Journal:  J Leukoc Biol       Date:  2020-01-22       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.